Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 41, Issue 4, Pages 470-477Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b17-00750
Keywords
Alzheimer's disease; anti-inflammation; antioxidant; Drosophila; extracellular-signal-regulated kinase; Nardostachys jatamansi
Categories
Funding
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1A2B4004241, 2016R1D1A1B03932530]
Ask authors/readers for more resources
The Nardostachys jatamansi DC (NJ) root has been used as a sedative or analgesic to treat neurological symptoms and pain in traditional Korean medicine. Here, we investigate the potential effects of NJ on Alzheimer's disease (AD) and reveal the molecular mechanism through which NJ exerts its effects. The neuroprotective effect of the NJ root ethanol extract against beta amyloid (A beta) toxicity was examined in vitro using a cell culture system and in vivo using a Drosophila AD model. The NJ extract and chlorogenic acid, a major component of NJ, inhibited A beta-induced cell death in SH-SY5Y cells. Moreover, the NJ extract rescued the neurological phenotypes of the A beta 42-expressing flies (decreased survival and pupariation rate and a locomotor defect) and suppressed A beta 42-induced cell death in the brain. We also found that NJ extract intake reduced glial cell number, reactive oxygen species level, extracellular-signal-regulated kinase (ERK) phosphorylation, and nitric oxide level in A beta 42-expressing flies, without affecting A beta accumulation. These data suggest that the neuroprotective activity of NJ might be associated with its antioxidant and anti-inflammatory properties, as well as its inhibitory action against ERK signaling; thus, NJ is a promising medicinal plant for the development of AD treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available